Proanthocyanidins Should Be a Candidate in the Treatment of Cancer, Cardiovascular Diseases and Lipid Metabolic Disorder

The conventional view of using medicines as routine treatment of an intractable disease is being challenged in the face of extensive and growing evidence that flavonoids in foods, especially proanthocyanidins (PAs), can participate in tackling fatal diseases like cancer, cardiovascular and lipid met...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tsz Ki, Xu, Shaoting, Li, Shuang, Zhang, Yunjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766935/
https://www.ncbi.nlm.nih.gov/pubmed/33339407
http://dx.doi.org/10.3390/molecules25245971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766935/
https://www.ncbi.nlm.nih.gov/pubmed/33339407
http://dx.doi.org/10.3390/molecules25245971

Ejemplares similares